SV

Sreekanth V

Active Director Director DIN 09630867
DIN 09630867 First appointment Jun 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Sreekanth V

Data last updated:

Sreekanth V is a Director at Medimark Laboratories Private Limited (since 2022). The company operates in Healthcare. Medimark Laboratories Private Limited reported revenue of ₹20,834 (FY 2023).

DIN 09630867
Primary Designation Director
Industry Healthcare
First Appointment 06 Jun 2022
Oldest Company Age 4 yrs
Largest company Medimark Laboratories Private Limited · ₹20,834 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jun 20222022₹20,834 (FY 2023)Active

Board colleagues of Sreekanth V

NameDINCompanyDesignation
Vishnu V09548473Medimark Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medimark Laboratories Private Limited
Premium access

Shareholding and investment profile for Sreekanth V

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreekanth V

Sreekanth V currently holds 1 directorship: Medimark Laboratories Private Limited (Director, since 06 Jun 2022, revenue ₹20,834 (FY 2023)).

Sreekanth V was first appointed on 06 Jun 2022 as Director at Medimark Laboratories Private Limited.

The current boards of Sreekanth V's companies include Vishnu V (Medimark Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available